Effects of deoxycorticosterone on renal vascular reactivity and flow-pressure curve in spontaneously hypertensive rats

Journal of Physiology and Pharmacology

Volumn 55, Issue 1 I, 2004, Pages 17-26

  Chamorro, V ^a   Moreno, J M ^a   Wangensteen, R ^a   Sainz, J ^a   Rodriguez Gomez I ^a   Osuna, A ^a   Vargas, F ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

DOCA; Flow pressure curve; SHR; Vasoconstrictors; Vasodilators

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; DEOXYCORTICOSTERONE; MINERALOCORTICOID; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL FUNCTION; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR FUNCTION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; FLOW PRESSURE CURVE; INJURY; ISOLATED KIDNEY; KIDNEY BLOOD VESSEL; MALE; NONHUMAN; PLOTS AND CURVES; RAT; RAT STRAIN; RESISTANCE BLOOD VESSEL; SODIUM RETENTION; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; DESOXYCORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; KIDNEY; MUSCLE, SMOOTH, VASCULAR; NITROPRUSSIDE; PERFUSION; PHENYLEPHRINE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RENAL CIRCULATION; RENAL VEINS; TIME FACTORS; VASCULAR RESISTANCE;

EID: 1942439791     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ngarmukos C, Grekin RJ. Nontraditional aspects of aldosterone physiology. Am J Physiol 2001; 281: E1122-1127.
2. Duprez D, De Buyzere M, Rietzschel ER, Clement DL. Aldosterone and vascular damage. Curr Hypertens Rep 2000; 2: 327-334.
3. Stier CT Jr, Chander PN, Rocha R. Aldosterone as a mediator in cardiovascular injury. Cardiol Rev 2002; 10: 97-107.
4. Wehling M. Aldosterone specific membrane receptors, rapid activation of the sodium-hydrogen exchanger, and cardiovascular implications. Cardiovasc Res 1995; 29: 167-171.
5. Drayer JIM, Weber MA, Purdy RE, Lipson JL. The effects of steroid hormones on vascular tissue. J Cardiovasc Pharmacol 1984; 6 (suppl 2): S394-S400.
6. Jones AW, Smith JM. Altered Ca-dependent fluxes of 42K in rat aorta during aldosterone-salt hypertension. Prog Clin Biol Res 1986; 219: 256-279.
7. Wehling M, Neylon CB, Fullerton M, Bobik A, Funder JW. Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells. Circ Res 1995; 76: 973-979.
8. Selye H, Hall CE, Rowley EM. Malignant hypertension produced by treatment with deoxycorticosterone acetate and sodium chloride. Can Med Assoc J 1943; 49: 88-92.
9. Alvarez G, Osuna A, Wangensteen R, Vargas F. Interaction between nitric oxide and mineralocorticoids in long-term control of blood pressure. Hypertension 2000; 35: 752-757.
10. De Gracia MC, Osuna A, O' Valle F, Del Moral RG, Wangensteen R, Garcia del Rio C, Vargas F. Deoxycorticosterone suppresses the effects of losartan in nitric oxide-deficient hypertensive rats. J Am Soc Nephrol 2000; 11: 1995-2000.
11. Pörsti I, Arvola P, Wourela H, Ilkka M, Säynävälammi P, Huhtala H, Metsä-Ketelä, Vapaatalo H. Effects of high calcium diet and deoxycorticosterone on vascular smooth muscle responses in spontaneously hypertensive rats. J Hypertens 1990; 8: 835-841.
12. Pörsti I, Wourela H, Arvola P, Säynävälammi P, Nurmi A-K, Huhtala H, Laippala P, Metsä-Ketelä, Vapaatalo H. Effects of high calcium and deoxycorticosterone on blood pressure, plasma renin activity and vascular reactivity in spontaneously hypertensive rats. Clin Exp Hypertens A 1990; 12: 1159-1174.
13. Vargas F, Fernández-Rivas A, Osuna A. Vascular reactivity and flow-pressure curve in isolated perfused kidneys from L-NAME hypertensive rats. JHypertens 1996; 14: 373-379.
14. Fernández O, Wangensteen R, Osuna A, Vargas F. Renal vascular reactivity to P2-purinoceptor activation in spontaneously hypertensive rats. Pharmacology 2000; 60: 47-50.
15. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside, and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981; 218: 739-749.
16. Folkow B, Hallback M, Lundgren Y, Weiss L. Background of increased flow resistance and vascular reactivity in spontaneously hypertensive rats. Acta Physiol Scand 1970; 80: 93-106.
17. Colis MG, Vanhoutte PM. Vascular reactivity of isolated perfused kidneys from male and female spontaneously hypertensive rats. Circ Res 1977; 41: 759-67.
18. Burton GA, Haylor J, Jonge A. Renal sensitivity to endothelium-derived-relaxing-factor-mediated vasodilation in the spontaneously hypertensive rat. Clin Sci 1991; 80: 435-441.
19. Lockette W, Otsuka Y, Carretero O. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 1986; 8 (suppl II): II-61-II-66.
20. Miller MJS, Pinto A, Mullane KM. Impaired endothelium-dependent relaxation in rabbits subjected to aortic coarctation hypertension. Hypertension 1987; 10: 164-170.
21. Bell DR, Bohr DF. Endothelium in functional aortic changes of coarctation hypertension. Am J Physiol 1991; 260: H1187-H1193.
22. Winquist RJ, Blunting PB, Baskin EP, Wallace AA. Decreased endothelium-dependent relaxation in New Zealand genetic hypertensive rats. J Hypertens 1984; 2: 541-545.
23. Tesfamariam B, Halpern W. Endothelium-dependent and endothelium-independent vasodilation in resistance arteries from hypertensive rats. Hypertension 1988; 11: 440-444.